Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 180

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Increased 90-Day Mortality in Patients With Acute Heart Failure With Elevated Copeptin: Secondary Results From the Biomarkers in Acute Heart Failure (BACH) Study

Maisel, Alan, Xue, Yang, Shah, Kevin, Mueller, Christian, Nowak, Richard, Peacock, W. Frank, Ponikowski, Piotr, Mockel, Martin, Hogan, Christopher, Wu, Alan H.B., Richards, Mark, Clopton, Paul, Filippatos, Gerasimos S., Di Somma, Salvatore, Anand, Inder S., Ng, Leong, Daniels, Lori B., Neath, Sean-Xavier, Christenson, Robert, Potocki, Mihael, McCord, James, Terracciano, Garret, Kremastinos, Dimitrios, Hartmann, Oliver, von Haehling, Stephan, Bergmann, Andreas, Morgenthaler, Nils G., Anker, Stefan D. · 2011 · Circulation: Heart Failure

Abstract

Background—: In patients with heart failure (HF), increased arginine vasopressin concentrations are associated with more severe disease, making arginine vasopressin an attractive target for therapy. However, AVP is difficult to measure due to its in vitro instability and rapid clearance. Copeptin, the C-terminal segment of preprovasopressin, is a stable and reliable surrogate biomarker for serum arginine vasopressin concentrations. Methods and Results—: The Biomarkers in Acute Heart Failure (BACH) trial was a 15-center, diagnostic and prognostic study of 1641 patients with acute dyspnea; 557 patients with acute HF were included in this analysis. Copeptin and other biomarker measurements were performed by a core laboratory at the University of Maryland. Patients were followed for up to 90 days after initial evaluation for the primary end point of all-cause mortality, HF-related readmissions, and HF-related emergency department visits. Patients with copeptin concentrations in the highest quartile had increased 90-day mortality ( P <0.001; hazard ratio, 3.85). Mortality was significantly increased in patients with elevated copeptin and hyponatremia ( P <0.001; hazard ratio, 7.36). Combined end points of mortality, readmissions, and emergency department visits were significantly increased in patients with elevated copeptin. There was no correlation between copeptin and sodium ( r =0.047). Conclusions—: This study showed significantly increased 90-day mortality, readmissions, and emergency department visits in patients with elevated copeptin, especially in those with hyponatremia. Copeptin was highly prognostic for 90-day adverse events in patients with acute HF, adding prognostic value to clinical predictors, ser um sodium, and natriuretic peptides. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00537628.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circheartfailure.110.960096

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 180

Metadata

Authors
Maisel, A., Xue, Y., Shah, K., Mueller, C., Nowak, R., Peacock, W. F., Ponikowski, P., Mockel, M., Hogan, C., Wu, A. H. B., Richards, M., Clopton, P., Filippatos, G. S., Di Somma, S., Anand, I. S., Ng, L., Daniels, L. B., Neath, S.-X., Christenson, R., Potocki, M., McCord, J., Terracciano, G., Kremastinos, D., Hartmann, O., von Haehling, S., Bergmann, A., Morgenthaler, N. G., & Anker, S. D.
Venue
Circulation: Heart Failure
Published
2011-09
Volume
4
Issue
5
Pages
613-620
ISSN
  • 1941-3289 (ISSN-L)
  • 1941-3297
OpenAlex
W2547101730
Cited by
180
References
1
FWCI
12.51
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased 90-Day Mortality in Patients With Acute Heart Failure With Elevated Copeptin: Secondary Results From the Biomarkers in Acute Heart Failure (BACH) Study. https://app.cochat.ai/papers/10.1161/circheartfailure.110.960096
The paper
Maisel, A., Xue, Y., Shah, K., Mueller, C., Nowak, R., Peacock, W. F., Ponikowski, P., Mockel, M., Hogan, C., Wu, A. H. B., Richards, M., Clopton, P., Filippatos, G. S., Di Somma, S., Anand, I. S., Ng, L., Daniels, L. B., Neath, S.-X., Christenson, R., . . . Anker, S. D. (2011). Increased 90-Day Mortality in Patients With Acute Heart Failure With Elevated Copeptin: Secondary Results From the Biomarkers in Acute Heart Failure (BACH) Study. Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.110.960096

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.